James Boy­lan snags $300M to hunt for biotech deals af­ter leav­ing SVB

Af­ter three decades in health­care in­vest­ment bank­ing, cul­mi­nat­ing in serv­ing as SVB pres­i­dent, James Boy­lan is head­ed to the oth­er side of the in­dus­try. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER